Latest filing published 13 Apr 2026 for Foghorn Therapeutics Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adrian Gottschalk: trading record in brief
Adrian Gottschalk, listed as chief executive, appears in our data through filings on Foghorn Therapeutics Inc. shares, published by SEC (Form 4). The record holds 23 filings, for trades running from 27 October 2020 to 10 April 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 13 April 2026 with a transaction in Foghorn Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Adrian Gottschalk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,497 shares0Common StockSEC:0001828724-26-000005:0
- 47,497 shares0Common StockSEC:0001828724-26-000005:1
- 59,208 shares0Common StockSEC:0001828724-26-000005:2
- 59,208 shares0Common StockSEC:0001828724-26-000005:3
- 300,000 shares0Common StockSEC:0001562180-25-003257:0
- 197,906 shares0Common StockSEC:0001562180-25-003092:0
- 63,000 shares0Common StockSEC:0001562180-23-006432:0
- 300,000 shares0Common StockSEC:0001562180-23-004642:0
- 123,479 shares0Common StockSEC:0001562180-23-001675:0
- 40,000 shares@ US$0.5450.4% of flowCommon StockSEC:0001562180-22-006726:0
- 23,000 shares@ US$0.5433.0% of flowCommon StockSEC:0001562180-21-005521:0
11 of 11 declarations